Specific receptor subtype mediation of LPA-induced dual effects in cardiac fibroblasts

被引:47
作者
Chen, Jinghai
Han, Yu
Zhu, Weiquan
Ma, Rui
Han, Bianmei
Cong, Xiangfeng
Hu, Shengshou [1 ]
Chen, Xi
机构
[1] Chinese Acad Med Sci, Res Ctr Cardiovasc Regenerat Med, Cardiovasc Inst, Beijing 100037, Peoples R China
[2] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100037, Peoples R China
[3] Peking Union Med Coll, Beijing 100037, Peoples R China
基金
中国国家自然科学基金;
关键词
cardiac fibroblasts; LPA; proliferation; apoptosis; receptor; caspase-3; cell viability; mitochondrial dysfunction; LYSOPHOSPHATIDIC ACID; T-CELLS; APOPTOSIS; LYSOPHOSPHOLIPIDS; MECHANISMS; GROWTH; IDENTIFICATION; ANTAGONISTS; ACTIVATION; MIGRATION;
D O I
10.1016/j.febslet.2006.07.061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Lysophosphatidic acid (LPA) is a phospholipid messenger with diverse effects mediated via receptors LPA1, LPA2 and LPA3. Our previous study revealed that serum LPA level is elevated after myocardial infarction (MI). However, very little is known about the effects of LPA on cardiac fibroblasts (CFs) that play a crucial role in left ventricular remodeling after MI. Here we demonstrated that LPA dose-dependently induced proliferation and collagen synthesis with the maximum stimulation at 10 mu M that was preferentially mediated by LPA3. LPA also dose-dependently induced apoptotic cell death, as estimated by MTT assay, hoechst staining, TUNEL and flow cytometric analysis, with an IC50 of 50 mu M. Moreover, apoptotic cell death may involve mitochondrial dysfunction and activation of caspase-3. Apoptosis induced by LPA might be mediated by LPA1. These data suggest that LPA exerts dual proliferative and proapoptotic actions mediated by specific LPA receptor subtypes. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:4737 / 4745
页数:9
相关论文
共 39 条
[1]
Cell surface receptors in lysophospholipid signaling [J].
Anliker, B ;
Chun, J .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2004, 15 (05) :457-465
[2]
MOLECULAR SIGNALING MECHANISMS CONTROLLING GROWTH AND FUNCTION OF CARDIAC FIBROBLASTS [J].
BOOZ, GW ;
BAKER, KM .
CARDIOVASCULAR RESEARCH, 1995, 30 (04) :537-543
[3]
Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction [J].
Chen, X ;
Yang, XY ;
Wang, ND ;
Ding, C ;
Yang, YJ ;
You, ZJ ;
Su, Q ;
Chen, JH .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2003, 63 (7-8) :497-503
[4]
Du J, 2000, J CELL BIOCHEM, V77, P333, DOI 10.1002/(SICI)1097-4644(20000501)77:2<333::AID-JCB15>3.0.CO
[5]
2-Q
[6]
EGHBALI M, 1992, BASIC RES CARDIOL, V87, P183
[7]
Lysophosphatidic acid prevents apoptosis in fibroblasts via Gi-protein-mediated activation of mitogen-activated protein kinase [J].
Fang, XJ ;
Yu, SX ;
LaPushin, R ;
Lu, YL ;
Furui, T ;
Penn, LZ ;
Stokoe, D ;
Erickson, JR ;
Bast, RC ;
Mills, GB .
BIOCHEMICAL JOURNAL, 2000, 352 :135-143
[8]
Fischer DJ, 2001, MOL PHARMACOL, V60, P776
[9]
Furui T, 1999, CLIN CANCER RES, V5, P4308
[10]
Lysophosphatidic acid as a phospholipid mediator: Pathways of synthesis [J].
Gaits, F ;
Fourcade, O ;
LeBalle, F ;
Gueguen, G ;
Gaige, B ;
GassamaDiagne, A ;
Fauvel, J ;
Salles, JP ;
Mauco, G ;
Simon, MF ;
Chap, H .
FEBS LETTERS, 1997, 410 (01) :54-58